| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,359 |
11,027 |
$401K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,771 |
5,185 |
$147K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,452 |
1,066 |
$77K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,151 |
698 |
$30K |
| 20610 |
|
1,826 |
1,029 |
$20K |
| 99442 |
|
1,995 |
944 |
$18K |
| 99223 |
Prolong inpt eval add15 m |
302 |
236 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
348 |
239 |
$6K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
431 |
74 |
$4K |
| 73562 |
|
466 |
275 |
$3K |
| 20553 |
|
490 |
369 |
$2K |
| 80305 |
|
647 |
501 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,268 |
1,667 |
$2K |
| 99443 |
|
163 |
92 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,751 |
1,083 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,580 |
822 |
$2K |
| 90688 |
|
568 |
279 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
262 |
188 |
$1K |
| 73030 |
|
54 |
40 |
$619.94 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
39 |
12 |
$509.52 |
| 99406 |
|
113 |
85 |
$331.29 |
| 36556 |
|
43 |
13 |
$299.40 |
| 99441 |
|
44 |
34 |
$299.25 |
| 82962 |
|
748 |
482 |
$280.31 |
| 62323 |
|
12 |
12 |
$274.81 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
43 |
41 |
$220.00 |
| 96160 |
|
368 |
280 |
$164.53 |
| 11721 |
|
33 |
15 |
$144.52 |
| 90686 |
|
25 |
12 |
$133.21 |
| 73630 |
|
31 |
14 |
$113.52 |
| 96127 |
|
121 |
88 |
$108.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
111 |
43 |
$84.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
12 |
$44.40 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
29 |
13 |
$36.64 |
| G0008 |
Administration of influenza virus vaccine |
368 |
250 |
$28.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
12 |
$4.20 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
489 |
146 |
$0.88 |
| 1036F |
|
5,050 |
3,428 |
$0.00 |
| 3079F |
|
1,124 |
803 |
$0.00 |
| 3074F |
|
2,400 |
1,757 |
$0.00 |
| 3008F |
|
5,306 |
3,767 |
$0.00 |
| 3080F |
|
553 |
371 |
$0.00 |
| 1125F |
|
1,568 |
1,009 |
$0.00 |
| 1170F |
|
114 |
53 |
$0.00 |
| 3075F |
|
656 |
476 |
$0.00 |
| 1126F |
|
1,682 |
1,067 |
$0.00 |
| 1034F |
|
720 |
488 |
$0.00 |
| 36416 |
|
179 |
126 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
30 |
12 |
$0.00 |
| 99024 |
|
84 |
52 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
26 |
26 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
18 |
12 |
$0.00 |
| 1101F |
|
12 |
12 |
$0.00 |
| 3077F |
|
1,551 |
1,004 |
$0.00 |
| 1159F |
|
2,290 |
1,537 |
$0.00 |
| 1160F |
|
2,184 |
1,533 |
$0.00 |
| 3078F |
|
2,828 |
2,002 |
$0.00 |
| 3725F |
|
152 |
112 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
59 |
25 |
$0.00 |
| 1090F |
|
31 |
25 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
79 |
53 |
$0.00 |